Search Results - "Nagao, Taeko"

Screening for basal marker expression is necessary for decision of therapeutic strategy for triple-negative breast cancer by Sasa, Mitsunori, Bando, Yoshimi, Takahashi, Masako, Hirose, Toshiyuki, Nagao, Taeko

“…Background Triple‐negative breast cancer (estrogen receptor‐negative, progesterone receptor‐negative and Her2‐negative) can be classified into two subtypes:…”
Get full text

The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia by Kanematsu, Miyuki, Morimoto, Masami, Honda, Junko, Nagao, Taeko, Nakagawa, Misako, Takahashi, Masako, Tangoku, Akira, Sasa, Mitsunori

“…The clinical predictors of aromatase inhibitor-related arthralgia (AIA), a drug-related adverse reaction of aromatase inhibitors (AIs), remain unclear. AIA was…”
Get full text

Current status of breast cancer screening in the world by Morimoto, Tadaoki, Nagao, Taeko, Okazaki, Kenji, Kira, Misako, Nakagawa, Yasushi, Tangoku, Akira

“…The mortality associated with breast cancer is decreasing in Europe and the United States. There are various reasons for these trends, including an increase in…”
Get full text

Among triple-negative breast cancers, HER2(0) breast cancer shows a strong tendency to be basal-like compared with HER2(1+) breast cancer: preliminary results by Nakagawa, Misako, Bando, Yoshimi, Nagao, Taeko, Takai, Chikako, Ohnishi, Takamasa, Honda, Junko, Moriya, Takuya, Izumi, Keisuke, Takahashi, Masako, Tangoku, Akira, Sasa, Mitsunori

“…Background Diagnosis of triple-negative breast cancer (ER-negative, PgR-negative, HER2-negative; TNBC) is performed by means of immunohistological staining…”
Get full text

Current status of sentinel lymph node navigation surgery in breast and gastrointestinal tract by Tangoku, Akira, Seike, Junichi, Nakano, Kiichiro, Nagao, Taeko, Honda, Junko, Yoshida, Takahiro, Yamai, Hiromichi, Matsuoka, Hisashi, Uyama, Kou, Goto, Masakazu, Miyoshi, Takanori, Morimoto, Tadaoki

“…Sentinel lymph node biopsy (SLNB) has been developed as a new diagnostic and therapeutic modality in melanoma and breast cancer surgery. The purpose of the…”
Get full text

Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration by Nagao, Taeko, Kira, Misako, Takahashi, Masako, Honda, Junko, Hirose, Toshiyuki, Tangoku, Akira, Zembutsu, Hitoshi, Nakamura, Yusuke, Sasa, Mitsunori

“…Aromatase inhibitor (AI) therapy is being extensively used as postoperative adjuvant therapy in patients with hormone receptor-positive postmenopausal breast…”
Get full text

Chromosomal Aneusomy (Chr 1, 11, 17) Detected by Fluorescence In Situ Hybridization May be a Prognostic Factor in Breast Cancer by TAKEHISA, Masatsugu, SASA, Mitsunori, BANDO, Yoshimi, HIROSE, Toshiyuki, MORIMOTO, Tadaoki, NAGAO, Taeko, TANGOKU, Akira

“…The relationship between clinicopathological findings and the long-term prognosis was investigated in 42 breast cancer patients in whom aneusomy was detected…”
Get full text

A case of matrix-producing carcinoma of the breast by Hirose, Toshiyuki, Honda, Junko, Bando, Yoshimi, Sasa, Mitsunori, Hirose, Yukiko, Nagao, Taeko, Tangoku, Akira

“…Matrix-producing carcinoma (MPC) of the breast is one variant type of metaplastic carcinoma. The cellular origin of MPC remains unclear. It has been suggested…”
Get full text

Matrix metalloproteinase inhibitor MMI-166 inhibits lymphogenous metastasis in an orthotopically implanted model of lung cancer by Fujino, Haruhiko, Kondo, Kazuya, Ishikura, Hisashi, Maki, Hideo, Kinoshita, Hidetaka, Miyoshi, Takanori, Takahashi, Yuji, Sawada, Naruhiko, Takizawa, Hiromitsu, Nagao, Taeko, Sakiyama, Shoji, Monden, Yasumasa

“…Matrix metalloproteinases (MMP) are considered to be critically involved in tumor invasion and the metastasis of various cancers. MMI-166 is a selective…”
Get full text

Joint Symptoms, Aromatase Inhibitor-Related Adverse Reactions, Are Indirectly Associated with Decreased Serum Estradiol by Kanematsu, Miyuki, Honda, Junko, Nakagawa, Misako, Takahashi, Masako, Nagao, Taeko, Tangoku, Akira, Sasa, Mitsunori

“…Background. Joint symptoms (JSs) are problematic adverse drug reactions (ADRs) of aromatase inhibitors (AIs). Involvement of decreased serum estradiol (SE) has…”
Get full text

Thymidine phosphorylase and dihydropyrimidine dehydrogenase are predictive factors of therapeutic efficacy of capecitabine monotherapy for breast cancer-preliminary results by Honda, Junko, Sasa, Mitsunori, Moriya, Takuya, Bando, Yoshimi, Hirose, Toshiyuki, Takahashi, Masako, Nagao, Taeko, Tangoku, Akira

“…Capecitabine monotherapy was administered for 25 patients with advanced or recurrent breast cancer, and the clinical therapeutic efficacy and its relationship…”
Get full text

False-positives in Fine-needle Aspiration Cytology of Breast Disease can be Reduced with p63 Immunostaining - A Preliminary Report by NAGAO, Taeko, BANDO, Yoshimi, SASA, Mitsunori, MORIMOTO, Tadaoki, SANO, Nobuya, HIROSE, Toshiyuki, TANGOKU, Akira

“…Myoepithelial cells of the mammary gland are considered to be a key to distinguishing benign from malignant disease in fine-needle aspiration (FNA) cytology…”
Get full text

Bilateral male breast cancer with male potential hypogonadism by Hirose, Yukiko, Sasa, Mitsunori, Bando, Yoshimi, Hirose, Toshiyuki, Morimoto, Tadaoki, Kurokawa, Yasushi, Nagao, Taeko, Tangoku, Akira

“…Male breast cancer is a comparatively rare disease, and simultaneous bilateral male breast cancer is considered to be an extremely rare event. Risk factors are…”
Get full text

Establishment of patient-like SCID mouse model by orthotopically implanting primary cultured cells from surgically-resected lung cancer tissues by Fujino, Haruhiko, Kondo, Kazuya, Miyoshi, Takanori, Ishikura, Hisashi, Takahashi, Yuji, Sawada, Naruhiko, Hirose, Yukiko, Takizawa, Hiromitsu, Nagao, Taeko, Sakiyama, Shoji, Monden, Yasumasa

“…In our previous studies, we established a lymphogenous metastatic SCID mouse model using orthotopic implantation of human lung cancer cell lines. However, the…”
Get more information

Lower axillary dissection in breast cancer surgery may be candidate for cases with early breast cancer by Takehisa, Masatsugu, Nagao, Taeko, Yoshida, Mitsuteru, Hirose, Toshiyuki, Kajikawa, Aiichiro, Sasa, Mitsunori, Tangoku, Akira

“…Lower axillary lymph node dissection (lower parts of both the level I and II elements below the second intracostobrachial nerve) and level I and II lymph node…”
Get full text

Safety evaluation of adjuvant chemotherapy by weekly paclitaxel combined with weekly carboplatin in patients with postoperative non-small cell lung cancer by Hirose, Toshiyuki, Nagao, Taeko, Kajikawa, Aiichiro, Sumi, Takanao, Sugimoto, Tomonori, Hirose, Yukiko, Yoshida, Mitsuteru, Kenzaki, Koichiro

“…Favorable results of various comparative studies have been reported in recent years regarding adjuvant chemotherapy for non-small cell lung cancer (NSCLC),…”
Get more information

The reduced expression and aberrant methylation of p16(INK4a) in chromate workers with lung cancer by Kondo, Kazuya, Takahashi, Yuji, Hirose, Yukiko, Nagao, Taeko, Tsuyuguchi, Masaru, Hashimoto, Masato, Ochiai, Atsushi, Monden, Yasumasa, Tangoku, Akira

“…It is known that chromium is one of the important inhaled carcinogens that cause lung cancer. Our previous studies revealed a variety of genetic changes in…”
Get full text

Algorithm for initiation of medication self-management training based on FIM (AIMS-F) in stroke patients by Furusato, Kyoko, Nagao, Taeko, Taketani, Masao, Nakazono, Hisato, Daisuke, Noguchi, Watanabe, Susumu

Get full text

Aberrant methylation of tumour-related genes in thymic epithelial tumours by Hirose, Yukiko, Kondo, Kazuya, Takizawa, Hiromitsu, Nagao, Taeko, Nakagawa, Yasushi, Fujino, Haruhiko, Toba, Hiroaki, Kenzaki, Koichiro, Sakiyama, Shoji, Tangoku, Akira

“…Summary Background Thymoma is an uncommon neoplasm derived from epithelial cells of the thymus. Few studies have addressed the genetic alterations that occur…”
Get full text

Expression of p53, Ki-67, E-Cadherin, N-Cadherin and TOP2A in Triple-negative Breast Cancer by NAKAGAWA, Misako, BANDO, Yoshimi, SASA, Mitsunori, TANGOKU, Akira, NAGAO, Taeko, MORIMOTO, Masami, TAKAI, Chikako, OHNISHI, Takamasa, HONDA, Junko, MORIYA, Takuya, IZUMI, Keisuke, TAKAHASHI, Masako

“…Elucidation of the biological features of triple negative breast cancer (TNBC) is important for deciding treatment strategies. The expression of a number of…”
Get full text